Cambrian Bio's last reported valuation, Aug 2023. Nothing priced has surfaced since.
- ·The complete investor list: 41 names
- ·Watch Cambrian Bio: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Cambrian Bio funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Dec 2025 | Later Stage VC | $23.8M | ▮ | ▮ |
Membership and data by Private Market View
Cambrian Bio valuation
Cambrian Bio's last reported valuation was $180 million in Aug 2023. No priced round, secondary trade or fund mark has surfaced since.
How much has Cambrian Bio raised?
Cambrian Bio has raised $204 million in total; 1 of its rounds is on record. The largest on record was a $23.8 million later-stage round in Dec 2025.
Institutional holders and vehicles
In the last 12 months, 1 investment vehicle was formed to buy Cambrian Bio shares, reporting $819,890 sold to 43 investors, per SEC Form D filings (most recent Jun 2026).
Comparable companies
Comparable drug discovery names by valuation on PrivateMarketView: Ajax Therapeutics ($193 million), Kinaset Therapeutics ($186 million) and Gordian Biotechnology ($170 million).
How Cambrian Bio's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Cambrian Bio, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by last reported valuation. Question about this number? Full methodology →
Frequently asked about Cambrian Bio
- What is Cambrian Bio worth?
- Cambrian Bio is valued at $180.0M as of Oct 2026. Cambrian Bio's last reported valuation, Aug 2023. Nothing priced has surfaced since.
- How much has Cambrian Bio raised?
- Cambrian Bio has raised $204.1M in total funding across 1 recorded rounds.
- When did Cambrian Bio last raise?
- Cambrian Bio last raised in Dec 2025 (Later Stage VC), raising $23.8M.